• Investor Home
  • Apollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare Conference

Apollo Endosurgery to Present at the Cantor Fitzgerald Global Healthcare Conference

Tuesday, September 19, 2017 3:01 pm CDT

Public Company Information:

NASDAQ:
APEN

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that company management is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26 at 9:10 am Eastern in New York, NY.

An audio webcast of the Company’s presentation will be available online at www.apolloendo.com and will be available for replay for 90 days.

Investors attending the conference who would like to schedule a one-on-one meeting with Apollo management may do so by contacting their Cantor Fitzgerald representative, or Lee Roth or Zack Kubow of The Ruth Group at apolloendo@theruthgroup.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today.

Apollo’s common stock is traded on NASDAQ Global Market under the symbol "APEN." For more information regarding Apollo Endosurgery, go to: apolloendo.com.

© 2017 Apollo Endosurgery, Inc. All rights reserved. Any third-party trademarks used herein are the property of their respective owners.

Contact:

Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
Chief Financial Officer
investor-relations@apolloendo.com
or
The Ruth Group
Lee Roth or Zack Kubow, 646-536-7000
apolloendo@theruthgroup.com

Business Wire InvestorHQ℠